TheStreet Lowers MSC Industrial Direct (NYSE:MSM) to C+

Friday, April 9, 2021 | MarketBeat

MSC Industrial Direct (NYSE:MSM) was downgraded by research analysts at TheStreet from a "b" rating to a "c+" rating in a note issued to investors on Wednesday, TheStreetRatingsTable reports.

A number of other brokerages have also recently issued reports on MSM. Zacks Investment Research cut shares of MSC Industrial Direct from a "hold" rating to a "sell" rating in a research note on Wednesday. Deutsche Bank Aktiengesellschaft dropped their price objective on MSC Industrial Direct from $90.00 to $89.00 and set a "hold" rating for the company in a report on Monday. Wells Fargo & Company upgraded MSC Industrial Direct from an "equal weight" rating to an "overweight" rating and raised their target price for the stock from $90.00 to $105.00 in a report on Thursday. Finally, William Blair raised MSC Industrial Direct from a "market perform" rating to an "outperform" rating in a research note on Wednesday. One analyst has rated the stock with a sell rating, four have given a hold rating and four have issued a buy rating to the stock. The company has a consensus rating of "Hold" and an average target price of $85.00.

MSC Industrial Direct stock opened at $90.00 on Wednesday. The business's 50-day simple moving average is $88.10 and its 200 day simple moving average is $80.61. The company has a quick ratio of 1.22, a current ratio of 2.23 and a debt-to-equity ratio of 0.41. The stock has a market cap of $5.02 billion, a price-to-earnings ratio of 22.33 and a beta of 0.99. MSC Industrial Direct has a 12-month low of $56.16 and a 12-month high of $93.92.

MSC Industrial Direct (NYSE:MSM) last released its earnings results on Tuesday, April 6th. The industrial products company reported $1.03 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.02 by $0.01. MSC Industrial Direct had a net margin of 7.14% and a return on equity of 20.42%. The company had revenue of $774.00 million for the quarter, compared to the consensus estimate of $778.77 million. During the same period in the prior year, the company posted $1.00 EPS. The company's revenue was down 1.5% compared to the same quarter last year. As a group, sell-side analysts expect that MSC Industrial Direct will post 4.65 EPS for the current year.

In other news, SVP Gregory Polli sold 15,570 shares of the company's stock in a transaction that occurred on Tuesday, February 16th. The shares were sold at an average price of $84.36, for a total value of $1,313,485.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Kari D. Heerdt sold 28,934 shares of the stock in a transaction on Thursday, March 11th. The stock was sold at an average price of $90.00, for a total transaction of $2,604,060.00. The disclosure for this sale can be found here. Over the last three months, insiders sold 81,339 shares of company stock valued at $7,019,914. Insiders own 28.44% of the company's stock.

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Fieldpoint Private Securities LLC acquired a new stake in shares of MSC Industrial Direct in the 4th quarter valued at about $40,000. JJJ Advisors Inc. raised its position in MSC Industrial Direct by 418.7% in the 4th quarter. JJJ Advisors Inc. now owns 555 shares of the industrial products company's stock valued at $47,000 after buying an additional 448 shares during the last quarter. Van ECK Associates Corp raised its position in MSC Industrial Direct by 29.9% in the 3rd quarter. Van ECK Associates Corp now owns 817 shares of the industrial products company's stock valued at $52,000 after buying an additional 188 shares during the last quarter. Captrust Financial Advisors lifted its stake in MSC Industrial Direct by 31.7% in the 3rd quarter. Captrust Financial Advisors now owns 2,300 shares of the industrial products company's stock valued at $143,000 after acquiring an additional 553 shares in the last quarter. Finally, AJO LP acquired a new position in MSC Industrial Direct during the 4th quarter worth approximately $197,000. 72.20% of the stock is owned by hedge funds and other institutional investors.

MSC Industrial Direct Company Profile

MSC Industrial Direct Co, Inc, together with its subsidiaries, distributes metalworking and maintenance, repair, and operations (MRO) products in the United States, Canada, Mexico, and the United Kingdom. Its MRO products include cutting tools, measuring instruments, tooling components, metalworking products, fasteners, flat stock products, raw materials, abrasives, machinery hand and power tools, safety and janitorial supplies, plumbing supplies, materials handling products, power transmission components, and electrical supplies.

Featured Story: Is it Safe to Invest in Commodities?

Analyst Recommendations for MSC Industrial Direct (NYSE:MSM)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]



7 Healthcare Stocks Delivering Innovation in 2021

We all knew that traditional healthcare services were disrupted in 2020. The patient-doctor relationship went virtual. In the early months of the pandemic, many people in need of elective surgeries simply did not have that option available to them. And even local pharmacies took on a new e-commerce role as curbside pickup or home delivery of prescription medication became the norm.

Not surprisingly healthcare stocks were battered last year. Overall, the sector was down 11%, far below the S&P 500 Index that climbed over 15%.

However, the market is always forward-looking with a particular eye towards innovation. The healthcare sector has many companies that are developing innovative approaches in areas such as gene editing. And other companies are in late-stage trials for drugs that can deliver breakthrough results for conditions that continue to plague our world.

That’s the focus of this presentation. We’ve identified 7 healthcare stocks that are delivering innovative ideas that will help deliver better patient outcomes. And in some cases will revolutionize medicine altogether. These are also the stocks that analysts have their eye on.

View the "7 Healthcare Stocks Delivering Innovation in 2021".


MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.